The homologue acts like a sling or leash between these two structures
Onset: noticeable within 2472 hours
Its dual receptor activity suggests potential advantages in metabolic regulation, but more extensive clinical data are needed to confirm its safety and effectiveness
Evaluation: Body fat (DXA scanning) Lean mass Insulin sensitivity Energy expenditure What they found: The combination showed an additive effect on fat reduction vs monotherapy AOD-9604 partially protected lean mass during GLP-1-induced weight reduction Increased energy expenditure in combination (~3 % vs GLP-1 alone) No new safety signals Why it matters: It validates the concept of combination , the idea that AOD-9604 may not work on its own, but can add value in combination with incretin agonists
(1998) The effect of copper peptides on wound healing, Dermatologic Surgery , 24(6), pp
This combination therapy has become increasingly popular among athletes, post-surgical patients, and individuals seeking comprehensive recovery support because it addresses multiple healing pathways simultaneously rather than relying on a single mechanism
